References
- Alanis-Hirsch, K., Croff, R., Ford, J. H., II, Johnson, K., Chalk, M., Schmidt, L., & McCarty, D. (2016). Extended-release naltrexone: A qualitative analysis of barriers to routine use. Journal of Substance Abuse Treatment, 62, 68–73. https://doi.org/https://doi.org/10.1016/j.jsat.2015.10.003
- Assefa, M. T., Ford, J. H., II, Osborne, E., McIlvaine, A., King, A., Campbell, K., Jo, B., & McGovern, M. P. (2019). Implementing integrated services in routine behavioral health care: Primary outcomes from a cluster randomized controlled trial. BMC Health Services Research, 19(1), 749. https://doi.org/https://doi.org/10.1186/s12913-019-4624-x
- Avery, J., Zerbo, E., & Ross, S. (2016). Improving psychiatrists' attitudes towards individuals with psychotic disorders and co-occurring substance use disorders. Academic Psychiatry, 40(3), 520–522. https://doi.org/https://doi.org/10.1007/s40596-015-0361-6
- Baigent, M. (2012). Managing patients with dual diagnosis in psychiatric practice. Current Opinion in Psychiatry, 25(3), 201–205. https://doi.org/https://doi.org/10.1097/YCO.0b013e3283523d3d
- Baker, A. L., Kavanagh, D. J., Kay-Lambkin, F. J., Hunt, S. A., Lewin, T. J., Carr, V. J., & Connolly, J. (2010). Randomized controlled trial of cognitive-behavioural therapy for coexisting depression and alcohol problems: Short-term outcome. Addiction, 105(1), 87–99. https://doi.org/https://doi.org/10.1111/j.1360-0443.2009.02757.x
- Bernstein, S. L., & D'Onofrio, G. (2017). Screening, treatment initiation, and referral for substance use disorders. Addiction Science & Clinical Practice, 12(1), 18. https://doi.org/https://doi.org/10.1186/s13722-017-0083-z
- Campbell, M. K., Piaggio, G., Elbourne, D. R., & Altman, D. G., CONSORT Group. (2012). Consort 2010 statement: Extension to cluster randomised trials. British Medical Journal, 345, e5661. https://doi.org/https://doi.org/10.1136/bmj.e5661
- Capoccia, V. A., Cotter, F., Gustafson, D. H., Cassidy, E. F., Ford, J. H., II, Madden, L., Owens, B. H., Farnum, S. O., McCarty, D., & Molfenter, T. (2007). Making “stone soup”: Improvements in clinic access and retention in addiction treatment. Joint Commission Journal on Quality and Patient Safety, 33(2), 95–103. https://doi.org/https://doi.org/10.1016/S1553-7250(07)33011-0
- Chi, F. W., Sterling, S., & Weisner, C. (2006). Adolescents with co-occurring substance use and mental conditions in a private managed care health plan: Prevalence, patient characteristics and treatment initiation and engagement. American Journal on Addictions, 15(s1), s67–s79. https://doi.org/https://doi.org/10.1080/10550490601006022
- Chokron Garneau, H., Assefa, M. T., Jo, B., Ford, J. H., II, Saldana, L., & McGovern, M. P. (2022). Sustainment of integrated care in addiction treatment settings: Primary outcomes from a cluster-randomized controlled trial. Psychiatric Services, 73(3), 280–286. https://doi.org/https://doi.org/10.1176/appi.ps.202000293
- Ford, J. H., II, Abraham, A. J., Lupulescu-Mann, N., Croff, R., Hoffman, K. A., Alanis-Hirsch, K., Chalk, M., Schmidt, L., & McCarty, D. (2017). Promoting adoption of medication for opioid and alcohol use disorders through system change. Journal of Studies on Alcohol and Drugs, 78(5), 735–744. https://doi.org/https://doi.org/10.15288/jsad.2017.78.735
- Ford, J. H., II, Green, C. A., Hoffman, K. A., Wisdom, J. P., Riley, K. J., Bergmann, L., & Molfenter, T. (2007). Process improvement needs in substance abuse treatment: Admissions walk-through results. Journal of Substance Abuse Treatment, 33(4), 379–389. https://doi.org/https://doi.org/10.1016/j.jsat.2007.02.003
- Ford, J. H., II, Osborne, E. L., Assefa, M. T., McIlvaine, A. M., King, A. M., Campbell, K., & McGovern, M. P. (2018). Using NIATx strategies to implement integrated services in routine care: A study protocol. BMC Health Services Research, 18(1), 431. https://doi.org/https://doi.org/10.1186/s12913-018-3241-4
- Gallucci, G., Swartz, W., & Hackerman, F. (2005). Brief reports: Impact of the wait for an initial appointment on the rate of kept appointments at a mental health center. Psychiatric Services, 56(3), 344–346. https://doi.org/https://doi.org/10.1176/appi.ps.56.3.344
- Garcia, S., Martinez-Cengotitabengoa, M., Lopez-Zurbano, S., Zorrilla, I., Lopez, P., Vieta, E., & Gonzalez-Pinto, A. (2016). Adherence to antipsychotic medication in bipolar disorder and schizophrenic patients: A systematic review. Journal of Clinical Psychopharmacology, 36(4), 355–371. https://doi.org/https://doi.org/10.1097/jcp.0000000000000523
- Getzen, H., Beasley, M., & D’Mello, D. A. (2013). Barriers to utilizing long-acting injectable antipsychotic medications. Annals of Clinical Psychiatry: Official Journal of the American Academy of Clinical Psychiatrists, 25(4), E1–E6. https://pubmed.ncbi.nlm.nih.gov/24660225/
- Gotham, H. J., Claus, R. E., Selig, K., & Homer, A. L. (2010). Increasing program capability to provide treatment for co-occurring substance use and mental disorders: Organizational characteristics. Journal of Substance Abuse Treatment, 38(2), 160–169. https://doi.org/https://doi.org/10.1016/j.jsat.2009.07.005
- Gustafson, D., Johnson, K., Capoccia, V., Cotter, F., Ford, J. H., II, Holloway, D., Lea, D., McCarty, D., Molfenter, T., & Owens, B. (2011). The NIATx model: Process improvement in behavioral health. University of Wisconsin-Madison.
- Gustafson, D. H., Quanbeck, A. R., Robinson, J. M., Ford, J. H., II, Pulvermacher, A., French, M. T., McConnell, K. J., Batalden, P. B., Hoffman, K. A., & McCarty, D. (2013). Which elements of improvement collaboratives are most effective? A cluster-randomized trial. Addiction, 108(6), 1145–1157. https://doi.org/https://doi.org/10.1111/add.12117
- Hassamal, S., Goldenberg, M., Ishak, W., Haglund, M., Miotto, K., & Danovitch, I. (2017). Overcoming barriers to initiating medication-assisted treatment for heroin use disorder in a general medical hospital: A case report and narrative literature Review. Journal of Psychiatric Practice, 23(3), 221-229. https://doi.org/https://doi.org/10.1097/pra.0000000000000231
- Ho, C. P., Zinski, A., Fogger, S. A., Peters, J. D., Westfall, A. O., Mugavero, M. J., Lawrence, S. T., Nevin, C. R., Raper, J. L., Saag, M. S., & Willig, J. H. (2015). Factors associated with missed psychiatry visits in an urban HIV clinic. AIDS and Behavior, 19(8), 1423–1429. https://doi.org/https://doi.org/10.1007/s10461-014-0967-9
- Hoffman, K. A., Ford, J. H., II, Choi, D., Gustafson, D. H., & McCarty, D. (2008). Replication and sustainability of improved access and retention within the Network for the Improvement of Addiction Treatment. Drug and Alcohol Dependence, 98(1–2), 63–69. https://doi.org/https://doi.org/10.1016/j.drugalcdep.2008.04.016
- Hoffman, K. A., Ford, J. H., II, Tillotson, C. J., Choi, D., & McCarty, D. (2011). Days to treatment and early retention among patients in treatment for alcohol and drug disorders. Addictive Behaviors, 36(6), 643–647. https://doi.org/https://doi.org/10.1016/j.addbeh.2011.01.031
- Hoffman, K. A., Green, C. A., Ford, J. H., II, Wisdom, J. P., Gustafson, D. H., & McCarty, D. (2012). Improving quality of care in substance abuse treatment using five key process improvement principles. The Journal of Behavioral Health Services & Research, 39(3), 234–244. https://doi.org/https://doi.org/10.1007/s11414-011-9270-y
- Jones, C. M., & McCance-Katz, E. F. (2019). Co-occurring substance use and mental disorders among adults with opioid use disorder. Drug and Alcohol Dependence, 197, 78–82. https://doi.org/https://doi.org/10.1016/j.drugalcdep.2018.12.030
- Karapareddy, V. (2019). A review of integrated care for concurrent disorders: Cost effectiveness and clinical outcomes. Journal of Dual Diagnosis, 15(1), 56–66. https://doi.org/https://doi.org/10.1080/15504263.2018.1518553
- Kelly, T. M., & Daley, D. C. (2013). Integrated treatment of substance use and psychiatric disorders. Social Work in Public Health, 28(3–4), 388–406. https://doi.org/https://doi.org/10.1080/19371918.2013.774673
- Knudsen, H. K., Abraham, A. J., & Oser, C. B. (2011). Barriers to the implementation of medication-assisted treatment for substance use disorders: The importance of funding policies and medical infrastructure. Evaluation and Program Planning, 34(4), 375–381. https://doi.org/http://dx.doi.org/10.1016/j.evalprogplan.2011.02.004
- Lambert-Harris, C., Saunders, E. C., McGovern, M. P., & Xie, H. (2013). Organizational capacity to address co-occurring substance use and psychiatric disorders: Assessing variation by level of care. Journal of Addiction Medicine, 7(1), 25–32. https://doi.org/https://doi.org/10.1097/ADM.0b013e318276e7a4
- Lindell, V. A., Stencel, N. L., Ives, R. C., Ward, K. M., Fluent, T., Choe, H. M., & Bostwick, J. R. (2018). A pilot evaluating clinical pharmacy services in an ambulatory psychiatry setting. Psychopharmacology Bulletin, 48(2), 18–28. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5875359/
- Malowney, M., Keltz, S., Fischer, D., & Boyd, J. W. (2015). Availability of outpatient care from psychiatrists: A simulated-patient study in three U.S. cities. Psychiatric Services, 66(1), 94–96. https://doi.org/https://doi.org/10.1176/appi.ps.201400051
- Martinez, C. P. (2020). Co-occurring psychiatric disorders. In C. Marienfeld (Ed.), Absolute addiction psychiatry review (pp. 335–348). Springer.
- McCarty, D., Gustafson, D. H., Wisdom, J. P., Ford, J., Choi, D., Molfenter, T., Capoccia, V., & Cotter, F. (2007). The Network for the Improvement of Addiction Treatment (NIATx): Enhancing access and retention. Drug and Alcohol Dependence, 88(2–3), 138–145. https://doi.org/https://doi.org/10.1016/j.drugalcdep.2006.10.009
- McGovern, M. P., Lambert-Harris, C., Gotham, H. J., Claus, R. E., & Xie, H. (2014). Dual diagnosis capability in mental health and addiction treatment services: An assessment of programs across multiple state systems. Administration and Policy in Mental Health and Mental Health Services Research, 41(2), 205–214. https://doi.org/https://doi.org/10.1007/s10488-012-0449-1
- McGovern, M. P., Lambert-Harris, C., McHugo, G. J., Giard, J., & Mangrum, L. (2010). Improving the dual diagnosis capability of addiction and mental health treatment services: Implementation factors associated with program level changes. Journal of Dual Diagnosis, 6(3–4), 237–250. https://doi.org/https://doi.org/10.1080/15504263.2010.537221
- McGovern, M. P., Matzkin, A. L., & Giard, J. (2007). Assessing the dual diagnosis capability of addiction treatment services: The Dual Diagnosis Capability in Addiction Treatment (DDCAT) Index. Journal of Dual Diagnosis, 3(2), 111–123. https://doi.org/https://doi.org/10.1300/J374v03n02_13
- Molfenter, T., Kim, J.-S., Quanbeck, A., Patel-Porter, T., Starr, S., & McCarty, D. (2013). Testing use of payers to facilitate evidence-based practice adoption: Protocol for a cluster-randomized trial. Implementation Science, 8(1), 50. https://doi.org/https://doi.org/10.1186/1748-5908-8-50
- Molfenter, T., McCarty, D., Jacobson, N., Kim, J.-S., Starr, S., & Zehner, M. (2019). The payer's role in addressing the opioid epidemic: It's more than money. Journal of Substance Abuse Treatment, 101, 72–78. https://doi.org/https://doi.org/10.1016/j.jsat.2019.04.001
- Molfenter, T., Sherbeck, C., Starr, S., Kim, J. S., Zehner, M., Quanbeck, A., Jacobson, N., & McCarty, D. (2018). Payer policy behavior towards opioid pharmacotherapy treatment in Ohio. Journal of Addiction Medicine, 12(2), 85–91. https://doi.org/https://doi.org/10.1097/adm.0000000000000369
- Novak, P., Feder, K. A., Ali, M. M., & Chen, J. (2019). Behavioral health treatment utilization among individuals with co-occurring opioid use disorder and mental illness: Evidence from a national survey. Journal of Substance Abuse Treatment, 98, 47–52. https://doi.org/https://doi.org/10.1016/j.jsat.2018.12.006
- Priester, M. A., Browne, T., Iachini, A., Clone, S., DeHart, D., & Seay, K. D. (2016). Treatment access barriers and disparities among individuals with co-occurring mental health and substance use disorders: An integrative literature review. Journal of Substance Abuse Treatment, 61, 47–59. https://doi.org/https://doi.org/10.1016/j.jsat.2015.09.006
- Quanbeck, A., Wheelock, A., Ford, J. H., II, Pulvermacher, A., Capoccia, V., & Gustafson, D. (2013). Examining access to addiction treatment: Scheduling processes and barriers. Journal of Substance Abuse Treatment, 44(3), 343–348. https://doi.org/https://doi.org/10.1016/j.jsat.2012.08.017
- Roman, P. M., Abraham, A. J., & Knudsen, H. K. (2011). Using medication-assisted treatment for substance use disorders: Evidence of barriers and facilitators of implementation. Addictive Behaviors, 36(6), 584–589. https://doi.org/https://doi.org/10.1016/j.addbeh.2011.01.032
- Roy, P. J., Choi, S., Bernstein, E., & Walley, A. Y. (2020). Appointment wait-times and arrival for patients at a low-barrier access addiction clinic. Journal of Substance Abuse Treatment, 114, 108011. https://doi.org/https://doi.org/10.1016/j.jsat.2020.108011
- Roy, P. J., Price, R., Choi, S., Weinstein, Z. M., Bernstein, E., Cunningham, C. O., & Walley, A. Y. (2021). Shorter outpatient wait-times for buprenorphine are associated with linkage to care post-hospital discharge. Drug and Alcohol Dependence, 224, 108703. https://doi.org/https://doi.org/10.1016/j.drugalcdep.2021.108703
- Sacks, S., Chaple, M., Sirikantraporn, J., Sacks, J. Y., Knickman, J., & Martinez, J. (2013). Improving the capability to provide integrated mental health and substance abuse services in a state system of outpatient care. Journal of Substance Abuse Treatment, 44(5), 488–493. https://doi.org/https://doi.org/10.1016/j.jsat.2012.11.001
- Schmidt, L. A., Rieckmann, T., Abraham, A., Molfenter, T., Capoccia, V., Roman, P., Gustafson, D. H., & McCarty, D. (2012). Advancing recovery: Implementing evidence-based treatment for substance use disorders at the systems level. Journal of Studies on Alcohol and Drugs, 73(3), 413–422. https://doi.org/https://doi.org/10.15288/jsad.2012.73.413
- Shover, C. L., Abraham, A., D'Aunno, T., Friedmann, P. D., & Humphreys, K. (2019). The relationship of Medicaid expansion to psychiatric comorbidity care within substance use disorder treatment programs. Journal of Substance Abuse Treatment, 105, 44–50. https://doi.org/https://doi.org/10.1016/j.jsat.2019.07.012
- Solmi, M., Fornaro, M., Ostinelli, E. G., Zangani, C., Croatto, G., Monaco, F., Krinitski, D., Fusar-Poli, P., & Correll, C. U. (2020). Safety of 80 antidepressants, antipsychotics, anti-attention-deficit/hyperactivity medications and mood stabilizers in children and adolescents with psychiatric disorders: a large scale systematic meta-review of 78 adverse effects. World Psychiatry, 19(2), 214–232. https://doi.org/https://doi.org/10.1002/wps.20765.
- Substance Abuse and Mental Health Services Administration. (2019). Key substance use and mental health indicators in the United States: Results from the 2018 National Survey on Drug Use and Health (HHS Publication No. PEP19-5068, NSDUH Series H-54). https://www.samhsa.gov/data/.
- Volkow, N. D., Jones, E. B., Einstein, E. B., & Wargo, E. M. (2019). Prevention and treatment of opioid misuse and addiction: A review. Journal of American Medical Association Psychiatry, 76(2), 208–216. https://doi.org/https://doi.org/10.1001/jamapsychiatry.2018.3126
- Volkow, N. D. (2020). Personalizing the treatment of substance use disorders. The American Journal of Psychiatry, 177(2), 113–116. https://doi.org/https://doi.org/10.1176/appi.ajp.2019.19121284
- Watkins, K. E., Hunter, S. B., Cohen, C. C., Leamon, I., Hurley, B., McCreary, M., & Ober, A. J. (2021). Organizational capacity and readiness to provide medication for individuals with co-occurring alcohol use disorders in public mental health settings. Administration and Policy in Mental Health and Mental Health Services Research, 48(4), 707–717. https://doi.org/https://doi.org/10.1007/s10488-020-01103-5
- Williams, M. E., Latta, J., & Conversano, P. (2008). Eliminating the wait for mental health services. The Journal of Behavioral Health Services & Research, 35(1), 107–114. https://doi.org/https://doi.org/10.1007/s11414-007-9091-1
- Young, J. Q., & Wachter, R. M. (2009). Applying Toyota Production System principles to a psychiatric hospital: Making transfers safer and more timely. The Joint Commission Journal on Quality and Patient Safety, 35(9), 439–448. https://doi.org/https://doi.org/10.1016/s1553-7250(09)35061-8